Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 63.1 M63.1 M65.3 M62 M 253.5 M Research & development ———— — Operating income 153.3 M155.2 M186.5 M206.9 M 701.9 M Non-Operating Income, Total 1.3 M-1.3 M-2.7 M2.9 M 200 K Interest expense, net of interest capitalized 12.7 M11.7 M10.6 M10.7 M 45.7 M Non-Operating Income, excl. Interest Expenses -14.4 M-13.6 M-12.2 M-12.9 M -53.1 M Unusual income/expense 3 M600 K-1.1 M5.1 M 7.6 M Pretax income 144.8 M130 M176.7 M204.7 M 656.2 M Equity in earnings ———— — Taxes 22.3 M24.7 M37.1 M42.3 M 126.4 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 122.5 M105.3 M139.6 M162.4 M 529.8 M Discontinued operations ———— — Net income 122.5 M105.3 M139.6 M162.4 M 529.8 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 122.5 M105.2 M139.5 M162.4 M 529.6 M Basic earnings per share (Basic EPS) 2.452.12.793.25 10.59 Diluted earnings per share (Diluted EPS) 2.432.092.773.23 10.52 Average basic shares outstanding 50.1 M50.1 M50 M49.9 M — Diluted shares outstanding 50.4 M50.3 M50.3 M50.2 M — EBITDA 252.1 M238.8 M288.3 M300.8 M 1.08 B EBIT 216.1 M202.6 M251.6 M262.6 M 932.9 M Cost of revenue 517.3 M509.7 M559.7 M582 M 2.17 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 36 M36.2 M36.7 M38.2 M 147.1 M